Find a lawyerOur capabilitiesYour career
Locations
Our capabilities
News

Select language:

Locations
Our capabilities
News

Select language:

hamburger menu showcase image
  1. Our thinking
  2. Blogs
  3. Technology Quotient
  4. Life sciences – what to watch in 2025
1MIN

Life sciences – what to watch in 2025

Jan 27 2025

We asked more than 200 Freshfields lawyers – across geographies and practice areas: what are the 1-2 issues top of mind for you and your clients going into 2025?

Here are the ten topics most frequently identified as areas to watch in 2025.

  1. Antitrust – maintained levels of heightened scrutiny and enforcement.
  2. Global protectionism – trend of increased restrictions to continue?
  3. Drug pricing – ongoing refinement of government programs.
  4. US litigation – increased focus on diligence clauses. 
  5. EU litigation – changes and uncertainties. 
  6. EU/UK regulatory oversight – ongoing reform. 
  7. MedTech - ongoing expansion and evolving legal issues.
  8. Deal-making - recent trends in biopharma. 
  9. ESG - increasing regulation in life sciences sector.
  10. US public health agencies - landscape under the Trump administration. 

Read the full report here.

***

Many thanks to the numerous Freshfields lawyers who contributed to this piece.

Tags

2024 electionsantitrust and competitionlife sciences transactionalm&amedtechforeign investmentlitigationregulatory framework

Authors

New York

Adam Golden

Global Head of Life Sciences
Washington, DC

Kristen Olvera Riemenschneider

Partner
Latest Insights

Latest Insights

NAVIGATE TO
About usLocations and officesYour careerOur thinkingOur capabilitiesNews
CONNECT
Find a lawyerAlumniContact us
NEED HELP
Fraud and scamsComplaintsTerms and conditions
LEGAL
AccessibilityCookiesLegal noticesTransparency in supply chains statementResponsible procurementPrivacy

Select language:
Select language:
© 2026 Freshfields. Attorney Advertising: prior results do not guarantee a similar outcome